<DOC>
	<DOCNO>NCT01045902</DOCNO>
	<brief_summary>The purpose trial determine efficacy safety Moxifloxacin comparison Sulbactam/Ampicillin treatment pulmonary abscess aspiration pneumonia .</brief_summary>
	<brief_title>BAY12-8039 , iv/Oral Pulmonary Abscess/Aspiration Pneumonia</brief_title>
	<detailed_description />
	<mesh_term>Pneumonia</mesh_term>
	<mesh_term>Abscess</mesh_term>
	<mesh_term>Pneumonia , Aspiration</mesh_term>
	<mesh_term>Lung Abscess</mesh_term>
	<mesh_term>Sulbactam</mesh_term>
	<mesh_term>Moxifloxacin</mesh_term>
	<mesh_term>Fluoroquinolones</mesh_term>
	<mesh_term>Ampicillin</mesh_term>
	<mesh_term>Norgestimate , ethinyl estradiol drug combination</mesh_term>
	<criteria>Male female patient age 18 year The primary diagnosis community hospital acquire primary pulmonary abscess aspiration pneumonia , require initial parenteral treatment Known hypersensitivity fluoroquinolones and/or ÃŸlactams Patients mechanical ventilation last 48 hour prior enrollment , poststenotic pneumonia , infarction pneumonia , pulmonary tuberculosis , lung abscess/pneumonia concomitant endocarditis</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2010</verification_date>
	<keyword>Pulmonary Abscess</keyword>
	<keyword>Aspiration Pneumonia</keyword>
</DOC>